Complementary use of mpMRI and genomic testing in prostate cancer

Around the Practice | <b>Around the Practice June 23, 2021: Genomic and Genetic Testing in Prostate Cancer</b>

Brian T. Helfand, MD, PhD, NorthShore University HealthSystem, discusses the value of using multiparametric MRI and genomic testing together when making treatment decisions in prostate cancer.

Related Content:

Around the Practice June 23, 2021: Genomic and Genetic Testing in Prostate CancerAround the PracticeGenomic Testing
A primer on DNA sequencing for the practicing urologist
FDA clears DTC report on marker of increased prostate cancer risk
Panel to discuss new data regarding TP53 mutations and prostate cancer risk